CONMED CNMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $13.83M-17.4% | $16.74M+485% | $2.86M-86.7% | $21.42M+255% | $6.04M-82.1% | ||
| $4.17M+2.7% | $4.07M-7.1% | $4.38M-2.0% | $4.47M+5.5% | $4.24M+0.9% | ||
| $5.5M+10.7% | $4.97M+8.4% | $4.59M-6.5% | $4.9M-64.6% | $13.86M+123% | ||
| $13.47M-70.9% | $46.34M-13.7% | $53.69M+84.3% | $29.13M-29.9% | $41.53M-4.2% | ||
| $2.89M-43.4% | $5.11M-1.5% | $5.19M-9.5% | $5.73M+51.6% | $3.78M-6.5% | ||
| $4.11M+158% | -$7.11M-37.1% | -$5.19M+9.5% | -$5.73M-95.6% | -$2.93M+27.5% | ||
| $0-100% | $6.19M0.0% | $6.19M0.0% | $6.19M+0.1% | $6.18M0.0% | ||
| $37.02M— | —— | —— | —— | $0— | ||
| $180M-3.7% | $187M+12.0% | $167M-4.8% | $175.43M+5.7% | $166M+10.7% | ||
| $0-100% | $20M-20.0% | $25M-37.9% | $40.23M+176% | $14.59M— | ||
| -$22.55M+39.6% | -$37.37M+14.1% | -$43.53M-64.1% | -$26.53M+6.6% | -$28.4M+44.4% | ||
| -$5.79M-407% | $1.89M-62.2% | $4.99M— | $0-100% | $11.03M— | ||
| $10.58M-74.3% | $41.22M-15.0% | $48.5M+107% | $23.41M-38.0% | $37.76M-3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CONMED generate?
- CONMED (CNMD) generated $142.6M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $18.9M of capital expenditures, CONMED's free cash flow was $123.7M over the trailing twelve months, down 24.8% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
